New Requirement - FFF unit with MALS/RI detectors

The Food and Drug Administration is forecasting a requirement for a single Field-flow fractionation system equipped with Multi-Angle Light Scattering and Refractive Index detectors, intended for advanced characterization of complex particles and macromolecules in biological and pharmaceutical samples. This acquisition is categorized under NAICS code 334516, which pertains to laboratory analytical instrument manufacturing, indicating the system must meet high-precision technical standards suitable for regulatory science applications. The opportunity was posted on May 25, 2026, and is currently in the forecast phase, meaning formal solicitation details have not yet been released but interested vendors should prepare for future competitive bidding. The place of performance and specific delivery location are not yet defined, though the equipment will likely be deployed at an FDA facility to support analytical research and compliance activities. The point of contact for program inquiries is the Oc Acquisition Liaison, reachable via ocacquisitions@fda.hhs.gov, while the contracting officer designation is pending. The lack of set-aside information suggests the opportunity may be open to all eligible small and large businesses without restrictions based on size or socioeconomic status. Vendors are encouraged to monitor the official public portal at the provided UI link for upcoming solicitation documents, as technical specifications, delivery timelines, and evaluation criteria will be detailed in subsequent announcements. No funding or contractual obligations exist at this stage, and submissions are not being accepted until a formal request for proposal is issued.